BACKGROUND: Better self management could improve quality of life (QoL) and reduce hospital admissions in chronic obstructive pulmonary disease (COPD), but the best way to promote it remains unclear. AIM: To explore the feasibility, effectiveness and cost effectiveness of a novel, layperson-led, theoretically driven COPD self-management support programme. DESIGN AND SETTING: Pilot randomised controlled trial in one UK primary care trust area. METHOD: Patients with moderate to severe COPD were identified through primary care and randomised 2:1 to the 7-week-long, group intervention or usual care. Outcomes at baseline, 2, and 6 months included self-reported health, St George's Respiratory Questionnaire (SGRQ), EuroQol, and exercise. RESULTS: Forty-four per cent responded to GP invitation, 116 were randomised: mean (standard deviation [SD]) age 69.5 (9.8) years, 46% male, 78% had unscheduled COPD care in the previous year. Forty per cent of intervention patients completed the course; 35% attended no sessions; and 78% participants completed the 6-month follow-up questionnaire. Results suggest that the intervention may increase both QoL (mean EQ-5D change 0.12 (95% confidence interval [CI] = -0.02 to 0.26) higher, intervention versus control) and exercise levels, but not SGRQ score. Economic analyses suggested that with thresholds of £20 000 per quality-adjusted life-year gained, the intervention is likely to be cost-effective. CONCLUSION: This intervention has good potential to meet the UK National Institute for Health and Clinical Excellence criteria for cost effectiveness, and further research is warranted. However, to make a substantial impact on COPD self-management, it will also be necessary to explore other ways to enable patients to access self-management education.
BACKGROUND: Better self management could improve quality of life (QoL) and reduce hospital admissions in chronic obstructive pulmonary disease (COPD), but the best way to promote it remains unclear. AIM: To explore the feasibility, effectiveness and cost effectiveness of a novel, layperson-led, theoretically driven COPD self-management support programme. DESIGN AND SETTING: Pilot randomised controlled trial in one UK primary care trust area. METHOD: Patients with moderate to severe COPD were identified through primary care and randomised 2:1 to the 7-week-long, group intervention or usual care. Outcomes at baseline, 2, and 6 months included self-reported health, St George's Respiratory Questionnaire (SGRQ), EuroQol, and exercise. RESULTS: Forty-four per cent responded to GP invitation, 116 were randomised: mean (standard deviation [SD]) age 69.5 (9.8) years, 46% male, 78% had unscheduled COPD care in the previous year. Forty per cent of intervention patients completed the course; 35% attended no sessions; and 78% participants completed the 6-month follow-up questionnaire. Results suggest that the intervention may increase both QoL (mean EQ-5D change 0.12 (95% confidence interval [CI] = -0.02 to 0.26) higher, intervention versus control) and exercise levels, but not SGRQ score. Economic analyses suggested that with thresholds of £20 000 per quality-adjusted life-year gained, the intervention is likely to be cost-effective. CONCLUSION: This intervention has good potential to meet the UK National Institute for Health and Clinical Excellence criteria for cost effectiveness, and further research is warranted. However, to make a substantial impact on COPD self-management, it will also be necessary to explore other ways to enable patients to access self-management education.
Authors: T Effing; E M Monninkhof; P D L P M van der Valk; J van der Palen; C L A van Herwaarden; M R Partidge; E H Walters; G A Zielhuis Journal: Cochrane Database Syst Rev Date: 2007-10-17
Authors: K R Lorig; D S Sobel; A L Stewart; B W Brown; A Bandura; P Ritter; V M Gonzalez; D D Laurent; H R Holman Journal: Med Care Date: 1999-01 Impact factor: 2.983
Authors: Kia Minna J Hynninen; Monica H Breitve; Alice B Wiborg; Ståle Pallesen; Inger Hilde Nordhus Journal: J Psychosom Res Date: 2005-12 Impact factor: 3.006
Authors: Kathryn L Rice; Naresh Dewan; Hanna E Bloomfield; Joseph Grill; Tamara M Schult; David B Nelson; Sarita Kumari; Mel Thomas; Lois J Geist; Caroline Beaner; Michael Caldwell; Dennis E Niewoehner Journal: Am J Respir Crit Care Med Date: 2010-01-14 Impact factor: 21.405
Authors: J Howland; E C Nelson; P B Barlow; G McHugo; F A Meier; P Brent; N Laser-Wolston; H W Parker Journal: Chest Date: 1986-08 Impact factor: 9.410
Authors: Anke Lenferink; Marjolein Brusse-Keizer; Paul Dlpm van der Valk; Peter A Frith; Marlies Zwerink; Evelyn M Monninkhof; Job van der Palen; Tanja W Effing Journal: Cochrane Database Syst Rev Date: 2017-08-04
Authors: Jade Schrijver; Anke Lenferink; Marjolein Brusse-Keizer; Marlies Zwerink; Paul Dlpm van der Valk; Job van der Palen; Tanja W Effing Journal: Cochrane Database Syst Rev Date: 2022-01-10
Authors: Sandra M Eldridge; Claire L Chan; Michael J Campbell; Christine M Bond; Sally Hopewell; Lehana Thabane; Gillian A Lancaster Journal: BMJ Date: 2016-10-24
Authors: Helen L Cameron-Tucker; Richard Wood-Baker; Christine Owen; Lyn Joseph; E Haydn Walters Journal: Int J Chron Obstruct Pulmon Dis Date: 2014-05-19
Authors: Stephanie J C Taylor; Dawn Carnes; Kate Homer; Brennan C Kahan; Natalia Hounsome; Sandra Eldridge; Anne Spencer; Tamar Pincus; Anisur Rahman; Martin Underwood Journal: PLoS Med Date: 2016-06-14 Impact factor: 11.069
Authors: Nini H Jonkman; Heleen Westland; Jaap Ca Trappenburg; Rolf Hh Groenwold; Erik Wma Bischoff; Jean Bourbeau; Christine E Bucknall; David Coultas; Tanja W Effing; Michael J Epton; Frode Gallefoss; Judith Garcia-Aymerich; Suzanne M Lloyd; Evelyn M Monninkhof; Huong Q Nguyen; Job van der Palen; Kathryn L Rice; Maria Sedeno; Stephanie Jc Taylor; Thierry Troosters; Nicholas A Zwar; Arno W Hoes; Marieke J Schuurmans Journal: Int J Chron Obstruct Pulmon Dis Date: 2016-08-31